ID   FUBP2_RAT               Reviewed;         721 AA.
AC   Q99PF5;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   24-JUL-2024, entry version 131.
DE   RecName: Full=Far upstream element-binding protein 2;
DE            Short=FUSE-binding protein 2;
DE   AltName: Full=KH type-splicing regulatory protein;
DE            Short=KSRP;
DE   AltName: Full=MAP2 RNA trans-acting protein 1;
DE            Short=MARTA1;
GN   Name=Khsrp; Synonyms=Fubp2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 73-87; 89-108 AND 475-486,
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=12358751; DOI=10.1046/j.1471-4159.2002.01058.x;
RA   Rehbein M., Wege K., Buck F., Schweizer M., Richter D., Kindler S.;
RT   "Molecular characterization of MARTA1, a protein interacting with the
RT   dendritic targeting element of MAP2 mRNAs.";
RL   J. Neurochem. 82:1039-1046(2002).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-182 AND SER-185, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Part of a ternary complex that binds to the downstream
CC       control sequence (DCS) of the pre-mRNA. Mediates exon inclusion in
CC       transcripts that are subject to tissue-specific alternative splicing.
CC       May interact with single-stranded DNA from the far-upstream element
CC       (FUSE). May activate gene expression. Also involved in degradation of
CC       inherently unstable mRNAs that contain AU-rich elements (AREs) in their
CC       3'-UTR, possibly by recruiting degradation machinery to ARE-containing
CC       mRNAs (By similarity). Binds to the dendritic targeting element and may
CC       play a role in mRNA trafficking. {ECO:0000250,
CC       ECO:0000269|PubMed:12358751}.
CC   -!- SUBUNIT: Part of a ternary complex containing FUBP2, PTBP1, PTBP2 and
CC       HNRPH1. Interacts with PARN. Interacts with PQBP1.
CC       {ECO:0000250|UniProtKB:Q92945}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12358751}. Cytoplasm
CC       {ECO:0000269|PubMed:12358751}. Note=A small proportion is also found in
CC       the cytoplasm of neuronal cell bodies and dendrites.
CC   -!- SIMILARITY: Belongs to the KHSRP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF308818; AAG59811.1; -; mRNA.
DR   RefSeq; NP_598286.1; NM_133602.1.
DR   AlphaFoldDB; Q99PF5; -.
DR   SMR; Q99PF5; -.
DR   BioGRID; 251142; 1.
DR   CORUM; Q99PF5; -.
DR   STRING; 10116.ENSRNOP00000072174; -.
DR   iPTMnet; Q99PF5; -.
DR   PhosphoSitePlus; Q99PF5; -.
DR   SwissPalm; Q99PF5; -.
DR   REPRODUCTION-2DPAGE; Q99PF5; -.
DR   jPOST; Q99PF5; -.
DR   PaxDb; 10116-ENSRNOP00000066023; -.
DR   AGR; RGD:621828; -.
DR   RGD; 621828; Khsrp.
DR   eggNOG; KOG1676; Eukaryota.
DR   InParanoid; Q99PF5; -.
DR   OrthoDB; 1662at2759; -.
DR   PhylomeDB; Q99PF5; -.
DR   Reactome; R-RNO-450604; KSRP (KHSRP) binds and destabilizes mRNA.
DR   PRO; PR:Q99PF5; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0010494; C:cytoplasmic stress granule; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0035925; F:mRNA 3'-UTR AU-rich region binding; ISS:UniProtKB.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:RGD.
DR   GO; GO:0003729; F:mRNA binding; ISO:RGD.
DR   GO; GO:0044183; F:protein folding chaperone; ISO:RGD.
DR   GO; GO:0061158; P:3'-UTR-mediated mRNA destabilization; ISS:UniProtKB.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; ISS:UniProtKB.
DR   GO; GO:0010586; P:miRNA metabolic process; ISS:UniProtKB.
DR   GO; GO:0006402; P:mRNA catabolic process; ISO:RGD.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0051028; P:mRNA transport; IEA:UniProtKB-KW.
DR   GO; GO:0010989; P:negative regulation of low-density lipoprotein particle clearance; ISO:RGD.
DR   GO; GO:0045019; P:negative regulation of nitric oxide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0061014; P:positive regulation of mRNA catabolic process; ISS:UniProtKB.
DR   GO; GO:2000628; P:regulation of miRNA metabolic process; ISO:RGD.
DR   GO; GO:0043488; P:regulation of mRNA stability; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   CDD; cd22479; KH-I_FUBP2_rpt1; 1.
DR   CDD; cd22482; KH-I_FUBP2_rpt2; 1.
DR   CDD; cd22485; KH-I_FUBP2_rpt3; 1.
DR   CDD; cd22488; KH-I_FUBP2_rpt4; 1.
DR   Gene3D; 3.30.1370.10; K Homology domain, type 1; 4.
DR   InterPro; IPR015096; FUBP_C.
DR   InterPro; IPR047372; KH-I_FUBP2_rpt1.
DR   InterPro; IPR047369; KH-I_FUBP2_rpt2.
DR   InterPro; IPR047370; KH-I_FUBP2_rpt3.
DR   InterPro; IPR047371; KH-I_FUBP2_rpt4.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   PANTHER; PTHR10288:SF101; FAR UPSTREAM ELEMENT-BINDING PROTEIN 2; 1.
DR   PANTHER; PTHR10288; KH DOMAIN CONTAINING RNA BINDING PROTEIN; 1.
DR   Pfam; PF09005; DUF1897; 2.
DR   Pfam; PF00013; KH_1; 4.
DR   SMART; SM00322; KH; 4.
DR   SUPFAM; SSF54791; Eukaryotic type KH-domain (KH-domain type I); 4.
DR   PROSITE; PS50084; KH_TYPE_1; 4.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; Direct protein sequencing; DNA-binding;
KW   Isopeptide bond; Methylation; mRNA processing; mRNA splicing;
KW   mRNA transport; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   RNA-binding; Transcription; Transcription regulation; Transport;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q92945"
FT   CHAIN           2..721
FT                   /note="Far upstream element-binding protein 2"
FT                   /id="PRO_0000050138"
FT   DOMAIN          145..209
FT                   /note="KH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          234..300
FT                   /note="KH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          323..387
FT                   /note="KH 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          425..492
FT                   /note="KH 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   REPEAT          572..583
FT                   /note="1"
FT   REPEAT          618..629
FT                   /note="2"
FT   REPEAT          644..655
FT                   /note="3"
FT   REPEAT          674..685
FT                   /note="4"
FT   REGION          1..148
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          394..422
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          498..570
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          572..685
FT                   /note="4 X 12 AA imperfect repeats"
FT   REGION          588..650
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          659..678
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          688..721
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        503..546
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        588..615
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92945"
FT   MOD_RES         40
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3U0V1"
FT   MOD_RES         88
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3U0V1"
FT   MOD_RES         101
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92945"
FT   MOD_RES         126
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92945"
FT   MOD_RES         130
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92945"
FT   MOD_RES         182
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         185
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         194
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92945"
FT   MOD_RES         275
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92945"
FT   MOD_RES         412
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92945"
FT   MOD_RES         414
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92945"
FT   MOD_RES         416
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92945"
FT   MOD_RES         443
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92945"
FT   MOD_RES         481
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92945"
FT   CROSSLNK        122
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q92945"
FT   CROSSLNK        122
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q92945"
SQ   SEQUENCE   721 AA;  74226 MW;  482C7A765C60EE4A CRC64;
     MSDYSTGGPP PGPPPPAGGG GGAAGAGGGP PPGPPGAGDR GGGGPGGGGP GGGGASGGPS
     QPPGGGGPGI RKDAFADAVQ RARQIAAKIG GDAATTVNNN TPDFGFGGQK RQLEDGDQPD
     SKKLASQGDS IGSQLGPIHP PPRTSMTEEY RVPDGMVGLI IGRGGEQINK IQQDSGCKVQ
     ISPDSGGLPE RSVSLTGAPE SVQKAKMMLD DIVSRGRGGP PGQFHDNANG GQNGTVQEIM
     IPAGKAGLVI GKGGETIKQL QERAGVKMIL IQDGSQNTNV DKPLRIIGDP YKVQQACEMV
     MDILRERDQG GFGDRNEYGS RVGGGIDVPV PRHSVGVVIG RSGEMIKKIQ NDAGVRIQFK
     QDDGTGPEKI AHIMGPPDRC EHAARIINDL LQSLRSGPPG PPGAPGMPPG GRGRGRGQGN
     WGPPGGEMTF SIPTHKCGLV IGRGGENVKA INQQTGAFVE ISRQLPPNGD PNFKLFVIRG
     SPQQIDHAKQ LIEEKIEGPL CPVGPGPGGP GPAGPMGPFH PGPFNQGPPG APPHAGGPPP
     HQYPPQGWGN TYPEWQPPAP HDPNKAAAAA TDPNAAWAAY YSHYYQQPPG PVPGPAPAPA
     APPAQGEPPQ PPPTGQSDYT KAWEEYYKKI GQQPQQPGAP PQQDYTKAWE EYYKKQAQVA
     TGGGPGAPPG SQPDYSAAWA EYYRQQAAYY GQTPGPGGPQ PPSTQQGQQQ ATEANGYELH
     L
//
